Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Merryn Voysey"'
Autor:
David R. Murdoch, Lisa K Stockdale, Meeru Gurung, Pratistha Maskey, Andrew J. Pollard, Bibek Khadka, Dominic F. Kelly, Piyush Rajbhandari, Stephen Thorson, Ganesh Shah, Merryn Voysey, Shrijana Shrestha, Madhav C. Gautam, Simon Kerridge, Sonu Shrestha, Bhishma Pokhrel, Shuo Feng, Sarah Kelly, Karin S Scherer
Publikováno v:
The Journal of Infectious Diseases
Background Reduction in detection of asymptomatic carriage of Haemophilus influenzae type b (Hib) can be used to assess vaccine impact. In Nepal, routine vaccination against Hib in children at 6, 10, and 14 weeks of age was introduced in 2009. Before
Autor:
Federica Cappuccini, P Cicconi, M Pace, Susanna Dunachie, Nishanta Singh, Catherine M. Green, Eleanor Barnes, Matthew Jones, J Fowler, Sarah C. Gilbert, N G Marchevsky, T Tipoe, C Fairhead, Yama F Mujadidi, M A Ansari, Teresa Lambe, S Serrano, P Goulder, P Zacharopoulou, S Broadhead, S Adele, F Ryan, Katie J. Ewer, L Parolini, Simon Kerridge, D Jenkin, Cooney E, Anele Waters, Christina Dold, Hill Avs., Parvinder K. Aley, Anthony Brown, Alison M. Lawrie, R Song, Paul Klenerman, Alexander D. Douglas, M Bittaye, M N Ramasamy, John Frater, Sarah Fidler, H Fok, Hannah Robinson, Mohammed K. Ali, Emily Adland, Angela M. Minassian, Julie Fox, Wanwisa Dejnirattisai, P M Folegatti, P Rongkard, C Petersen, Harriet R. Brown, Elizabeth A. Clutterbuck, Watson Mee., C Gibbs, N Robinson, Merryn Voysey, Emma Plested, J Alagaratnam, A Ogbe, S Bibi, A Bara, Alissa Goodman, Alan Winston, R Makinson, H Nguyen, Andrew J. Pollard, Gavin R. Screaton, S Rhead, Katrina M Pollock
Publikováno v:
The Lancet. HIV
e485
e474
e485
e474
Background: data on vaccine immunogenicity against SARS-CoV-2 are needed for the 40 million people globally living with HIV who might have less functional immunity and more associated comorbidities than the general population. We aimed to explore saf
Autor:
Firdausi Qadri, Karin Sofia Scherrer, Susan Tonks, Kamrul Islam, Melanie Greenland, Sarah Kelly, Mahzabeen Ireen, P J O’Reilly, Golap Babu, Prasanta Kumar Biswas, Katherine Theiss-Nyland, Shams Uddin Ahmed, Ismail Hossen, Nazmul Hasan Rajib, Kathleen M. Neuzil, Andrew J. Pollard, Merryn Voysey, Nicola Smith, John D. Clemens, Arifuzzaman Khan, Virginia E. Pitzer, Yama F Mujadidi, Xinxue Liu, Nazia Rahman, R Colin-Jones, Faisal Ahmmed, Farhana Khanam, O Mazur, Amirul Islam Bhuiyan, K. Zaman
Publikováno v:
The Lancet. 398:675-684
Background Typhoid fever remains a major cause of morbidity and mortality in low-income and middle-income countries. Vi-tetanus toxoid conjugate vaccine (Vi-TT) is recommended by WHO for implementation in high-burden countries, but there is little ev
Autor:
Shabir A, Madhi, Vicky, Baillie, Clare L, Cutland, Merryn, Voysey, Anthonet L, Koen, Lee, Fairlie, Sherman D, Padayachee, Keertan, Dheda, Shaun L, Barnabas, Qasim E, Bhorat, Carmen, Briner, Gaurav, Kwatra, Khatija, Ahmed, Parvinder, Aley, Sutika, Bhikha, Jinal N, Bhiman, As'ad E, Bhorat, Jeanine, du Plessis, Aliasgar, Esmail, Marisa, Groenewald, Elizea, Horne, Shi-Hsia, Hwa, Aylin, Jose, Teresa, Lambe, Matt, Laubscher, Mookho, Malahleha, Masebole, Masenya, Mduduzi, Masilela, Shakeel, McKenzie, Kgaogelo, Molapo, Andrew, Moultrie, Suzette, Oelofse, Faeezah, Patel, Sureshnee, Pillay, Sarah, Rhead, Hylton, Rodel, Lindie, Rossouw, Carol, Taoushanis, Houriiyah, Tegally, Asha, Thombrayil, Samuel, van Eck, Constantinos K, Wibmer, Nicholas M, Durham, Elizabeth J, Kelly, Tonya L, Villafana, Sarah, Gilbert, Andrew J, Pollard, Tulio, de Oliveira, Penny L, Moore, Alex, Sigal, Alane, Izu, Peter, Zuidewind
Publikováno v:
The New England Journal of Medicine : NEJM / Publ. by the Massachusetts Medical Society
Background Assessment of the safety and efficacy of vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in different populations is essential, as is investigation of the efficacy of the vaccines against emerging SARS-CoV
Autor:
Melita A. Gordon, Gordon Dougan, Maile T Phillips, Stephen Baker, Deus Thindwa, Firdausi Qadri, Buddha Basnyat, Thomas C. Darton, John D. Clemens, Merryn Voysey, Kathryn E. Holt, K. Zaman, Farhana Khanam, Susan Tonks, Sabina Dongol, Sarah J. Dunstan, Andrew J. Pollard, Abilasha Karkey, Christiane Dolecek, Mila Shakya, Virginia E. Pitzer, James E Meiring, Robert S Heyderman
Publikováno v:
The Lancet. Global Health
The Lancet Global Health, Vol 9, Iss 12, Pp e1688-e1696 (2021)
The Lancet Global Health, Vol 9, Iss 12, Pp e1688-e1696 (2021)
Background Enteric fever is a serious public health concern in many low-income and middle-income countries. Numerous data gaps exist concerning the epidemiology of Salmonella enterica serotype Typhi (S Typhi) and Salmonella enterica serotype Paratyph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a270ae48236a5e99ddb9a839e60d5dc
https://doi.org/10.1016/s2214-109x(21)00370-3
https://doi.org/10.1016/s2214-109x(21)00370-3
Autor:
Jennifer Hill, Xinxue Liu, A Pradhan, Anup Adhikari, Merryn Voysey, T Lubinda, Kathleen M. Neuzil, Andrew J. Pollard, O Mazur, B Bajracharya, N Haque, Dikshya Pant, Nicola Smith, Stephen Baker, Sarah Kelly, Anju Maharjan, A Dahal, Lisa Stockdale, Yama F Mujadidi, Shrijana Shrestha, Katherine Theiss-Nyland, Buddha Basnyat, R Colin-Jones, Mila Shakya, Gordon Dougan, Susan Tonks, Elizabeth Jones, Abhilasha Karkey, P J O’Reilly, M Joshi, Virginia E. Pitzer, J Clarke, Sabina Dongol
Publikováno v:
The Lancet Global Health, Vol 9, Iss 11, Pp e1561-e1568 (2021)
The Lancet. Global Health
The Lancet. Global Health
Background Typhoid fever is a major public health problem in low-resource settings. Vaccination can help curb the disease and might reduce transmission. We have previously reported an interim analysis of the efficacy of typhoid conjugate vaccine (TCV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bea1a1229e076666c9da2b9fd7a1e2fd
https://doi.org/10.1016/s2214-109x(21)00346-6
https://doi.org/10.1016/s2214-109x(21)00346-6
Autor:
Anouska Bharath, Bo Gao, Merryn Voysey, Rima Shretta, Andrew J. Pollard, Ricardo Aguas, Lisa J. White
Publikováno v:
Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
Nature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
The high efficacy, low cost, and long shelf-life of the ChAdOx1 nCoV-19 vaccine positions it well for use in in diverse socioeconomic settings. Using data from clinical trials, an individual-based model was constructed to predict its 6-month populati
Autor:
Andrew J. Pollard, Sarah Kelly, Celina Jin, R Colin-Jones, Jennifer Hill, Merryn Voysey, Sabina Dongol, Lisa Stockdale, Koeleman Cam., J Clarke, Jan Nouta, E Y Jones, Katherine Theiss-Nyland, Dikshya Pant, Shrijana Shrestha, N. de Haan, Manfred Wuhrer, Buddha Basnyat, M Johnson, Mila Shakya, Abhilasha Karkey, S Marinou
Publikováno v:
Frontiers in Tropical Diseases. 2
Typhoid Vi-conjugate vaccines (Vi-TCV) have been developed to control typhoid fever in children in endemic regions. Previously, in a human challenge model of typhoid, Vi-TCV was administered prior to deliberate ingestion of Salmonella Typhi by health
Autor:
Firdausi Qadri, Joshua L. Warren, Andrew J. Pollard, Maile T Phillips, Kathryn E. Holt, Virginia E. Pitzer, Stephen Baker, Sarah J. Dunstan, John D. Clemens, Christiane Dolecek, Gordon Dougan, Merryn Voysey, Melita A. Gordon, Buddha Basnyat, Robert S. Heyderman, Deus Thindwa, James E Meiring
Publikováno v:
Statistics in medicine. 40(26)
Decisions about typhoid fever prevention and control are based on estimates of typhoid incidence and their uncertainty. Lack of specific clinical diagnostic criteria, poorly sensitive diagnostic tests, and scarcity of accurate and complete datasets c
Autor:
Sonu Shrestha, Madhav C. Gautam, P J O’Reilly, Dominic F. Kelly, Imran Ansari, Biplav Shrestha, Merryn Voysey, Sarah Kelly, Sanjeev M Bijukchhe, Baikuntha Acharya, David R. Murdoch, Ganesh Shah, Mamata Maharjan, Rama Kandasamy, Andrew J. Pollard, Raju Pandit, Stephen Thorson, David Goldblatt, Parisa Hariri, Pratistha Maskey, Laxmi Lama, Ruby Basi, Katherine L. O'Brien, Meeru Gurung, Shrijana Shrestha, Manisha K C
Publikováno v:
The Pediatric infectious disease journal. 40(10)
Background: The pneumococcal conjugate vaccine has had a substantial impact on invasive pneumococcal disease. Previously, we compared immunity following vaccination with the 10-valent pneumococcal conjugate vaccine (PCV10) administered at 2 slightly